Kathelijn Fischer

Break‐through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A

P. Collins, Victor S. Blanchette, Kathelijn Fischer et al. · Journal of Thrombosis and Haemostasis · 2008 · 320 citations

Factor Viii Levels, Medicine, Hematology +7

Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study

Samantha C. Gouw, H. Marijke van den Berg, Kathelijn Fischer et al. · Blood · 2013 · 319 citations

Consensus perspectives on prophylactic therapy for haemophilia: summary statement

Erik Berntorp, Jan Astermark, Sven Björkman et al. · Haemophilia · 2003 · 270 citations · Full text

Consensus Summary, Preventive Medicine, Secondary Prophylaxis +14

The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia

Kathelijn Fischer, Johanna G. van der Bom, Eveline P. Mauser‐Bunschoten et al. · Blood · 2002 · 257 citations

Clinical severity of haemophilia A: does the classification of the 1950s still stand?

I. E. M. DEN UIJL, E. P. Mauser Bunschoten, G. Roosendaal et al. · Haemophilia · 2011 · 236 citations